• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

No overall survival benefits to regional nodal irradiation for early-stage breast cancer patients

byJon LiuandShaidah Deghan, MSc. MD
July 23, 2015
in Chronic Disease, Obstetrics, Oncology
Reading Time: 2 mins read
Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Share on FacebookShare on TwitterShare on LinkedIn

1. There was no significant 10 year survival benefit after axillary and medial supraclavicular nodal irradiation in patients with stages 1, 2 and 3 breast adenocarcinoma.

2. The study was initiated in the early 1990s, when adjuvant systemic therapy was not as variable then as it is today. Unfortunately, little information was collected on this potentially confounding variable.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: For most patients with breast cancer, adjuvant chemotherapy and radiation have become cornerstone therapies for maintaining remission post-mastectomy. Regional nodes such as internal mammary are not often involved with local cancer spread given the direction of lymphatic drainage. Surgical dissection of internal mammary nodes has been attempted in the past for axillary node-positive breast cancers with no difference in survival. However, regional node irradiation (ie. internal mammary and medial supraclavicular nodes) for these patients has never been well-studied in a large trial.

This multi-center trial randomized 4004 patients with stage 1, 2 or 3 breast adenocarcinoma to either regional irradiation or no irradiation. The primary endpoint of overall survival at 10 years follow-up was not statistically significant (nodal-irradiation versus none, 82.3% versus 80.7%, p=0.06). However, nodal-irradiation improved disease-free survival at 10 years and the rate of first recurrence of breast cancer at 10 years; both of which were secondary end points. Pulmonary fibrosis was a long-term side effect noted to be higher in the irradiated group (nodal-irradiation versus none, 4.4% versus 1.7%, p<0.001).

Over the past ten years, chemotherapies and biomarker profiling for breast cancer have quickly evolved. Breast cancer patients in this study were enrolled between 1996 and 2004 when fewer therapies were available and therefore the results of this study may not be generalizable to current patients with newer chemotherapies. Nevertheless, this study raises an interesting question as to where radiation fits in the complex subgroups of breast cancer patients that now have several lines of different therapies.

RELATED REPORTS

Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Click to read the study in the NEJM (New England Journal of Medicine)

Relevant Reading: 2011 European guidelines (ESMO) for diagnosis, treatment and follow-up of primary breast cancer

FDA approvedFor breast cancer: Wilserdly (giredestrant), Nov 16, 2026→

In-Depth [randomized controlled trial]: Between 1996 and 2004, a total of 4004 patients were enrolled from 46 institutions in 13 countries. Eligible patients had stages 1, 2 or 3 breast adenocarcinoma with some form of surgical reduction (ie. mastectomy or breast-conserving surgery with axillary dissection). Randomization occurred in a 1:1 fashion to either regional nodal irradiation or none. Baseline characteristics were well-matched. Primary tumour size was < 5cm in 95.8% of patients. Primary end point of overall survival was not statistically significant between the two groups. However, at 10 years, regional nodal irradiation improved disease-free survival (72.1% versus 69.1%, p=0.04) and lowered the rate of first recurrence of breast cancer (19.4% versus 22.9%, p=0.02). Further subgroup analysis adjusting for type of surgery, type of axillary node dissection, pathologic tumor-nodal staging did not reveal any statistical differences between groups. Acute side effects were small and the rate of death from all other causes were not increased.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast Cancer
Previous Post

Sexually dimorphic gray matter changes evident in patients with prior stimulant abuse

Next Post

Artificially sweetened beverage consumption may increase risk of type 2 diabetes

RelatedReports

A middle-aged woman looks thoughtfully at an abstract representation of cells and a statin pill, symbolizing breast cancer and medication usage.
Oncology

Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer

October 5, 2026
Sleep disorders collage: an engraved pillow and rumpled sheet with a dark sleep mask, a paper crescent moon and a teal ribbon
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Breast cancer care collage: a calm woman in a turtleneck sweater beside a folded paper crane and a small white pill bottle
Chronic Disease

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

August 13, 2026
Sleep disorders collage: an engraved pillow and rumpled sheet with a dark sleep mask, a paper crescent moon and a teal ribbon
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Next Post

Artificially sweetened beverage consumption may increase risk of type 2 diabetes

Low birth weight linked to increased risk of type 2 diabetes

Daily reading habits may be associated with higher surgery in-training examination performance

Daily reading habits may be associated with higher surgery in-training examination performance

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Less social media usage is associated with improved internalizing symptoms in high-risk young adults.
  • AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality
  • In a phase 3 trial, tirzepatide reduced BMI versus placebo in adolescents with obesity and obesity-related complications
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.